Company: CWAN
Filing Date: 2025-01-13
Form Type: 425
Source: 0001104659-25-003010
Chunk: 11

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-01-13
Form: 425
Chunk 11
---
fusion and Parent may
also file other relevant documents with the SEC regarding the proposed transaction. This document is not a substitute for the joint proxy
statement/prospectus or registration statement or any other document that Enfusion or Parent may file with the SEC. The definitive joint
proxy statement/prospectus (if and when available) will be mailed to stockholders of Enfusion. INVESTORS AND SECURITY HOLDERS ARE URGED
TO CAREFULLY READ THE REGISTRATION STATEMENT AND JOINT PROXY STATEMENT/PROSPECTUS IN THEIR ENTIRETY WHEN THEY BECOME AVAILABLE AND ANY
OTHER DOCUMENTS FILED WITH THE SEC IN CONNECTION WITH THE PROPOSED TRANSACTION AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS THERETO OR INCORPORATED
BY REFERENCE THEREIN BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION AND THE PARTIES TO THE PROPOSED TRANSACTION.
Investors and security holders may obtain free copies of the registration statement and joint proxy statement/prospectus (when available)
and other documents containing important information about Enfusion, Parent and the proposed transaction once such documents are filed
with the SEC through the website maintained by the SEC at http://www.sec.gov. Copies of the documents filed with the SEC by Enfusion will
be available free of charge on Enfusion’s website at https://ir.enfusion.com. Copies of the documents filed with the SEC by Parent
will be available free of charge on Parent’s website at https://investors.clearwateranalytics.com.

No Offer or Solicitation

This communication shall not constitute an offer to sell or the solicitation
of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or
sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities
shall be made except by means of a prospectus meeting the requirements of Section 10 of the U.S. Securities Act of 1933, as amended.

Participants in the Solicitation

Enfusion, Clearwater and certain of their
respective directors, executive officers and employees may be deemed to be participants in the solicitation of proxies in connection with
the proposed transaction. Information regarding the persons who may, under the rules of the SEC, be deemed to be participants in the solicitation
of proxies in connection with the proposed transaction, including a description of their respective direct or indirect interests, by security
holdings or otherwise,